HIV vaccine development: current challenges and emerging solutions
Supported by:
28 October 2024
3:00pm
Shares
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
In recent years, HIV research has made significant strides, bringing us closer to new preventative and therapeutic solutions. Join us for this webinar to gain insights into the latest advancements in HIV vaccine development, including challenges, breakthroughs and future directions in the field.
This webinar will offer a comprehensive exploration of the current landscape of HIV research. Our esteemed panel will provide detailed insights into the key challenges of HIV vaccine development, potential strategies to overcome them, and the crucial role of global collaboration in creating a brighter future for all.
We will also examine the significance of emerging technologies and discuss recent promising preclinical results, highlighting how these findings could translate into clinical trials. Furthermore, our experts will elucidate the present trends in the field and forecast potential advancements that we could see in the next five to 10 years.
Do not miss this opportunity to gain a deeper understanding of the cutting-edge developments and future directions in HIV research.
Key learning points:
- Key challenges in HIV vaccine development: HIV is notorious for its high genetic variability and immune evasion mechanisms. The complexity of immune response will also be explored, as well as the use of animal models, safety concerns, and regulatory and ethical issues.
- Overcoming these challenges: emerging technologies will be discussed, and the importance of global collaborative efforts highlighted.
- Recent promising preclinical studies: The promising results from recent preclinical studies will be discussed, as well as how these may translate into clinical trials.
- Trends and advancements in the field: The potential breakthroughs that may be observed in the next five to 10 years will be forecasted.
Join us as we explore the latest advancements in HIV vaccine development in a balanced and informative discussion.
Register to join this webinar for free!
Dr Jay Varma, Chief Medical Officer at SIGA Technologies Is the webinar free? When will the webinar take place? I’m busy. Can I watch it later? What are the benefits of attending live? How long will the webinar be? What do I need to watch this webinar? Do I receive a certificate?OUR SPEAKERS
Marcus Conant, previously Chief Medical Officer of Addimmune and American Gene Technologies (AGT) FAQs
Yes – there is no charge to watch the webinar, either live or on-demand.
The webinar will take place live on 28 October 2024 at 3PM GMT.
The webinar will become available to watch on-demand shortly after the live webinar takes place.
During the live webinar, you’ll be able to ask the speakers your questions, which will then be answered during the live Q&A session towards the end of the webinar.
This webinar will last for up to one hour.
All you need is a computer with an internet connection. Be sure to use headphones if in an office environment.
Yes, you will receive a certificate if you attend the webinar live. The certificate will be sent with your on-demand video link.